LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | GW843682X | 1.11 | uM | LJP6 | 72 | hr | 1097 | 1003 | 3769 | 0.2661 | -0.0353 |
| BT-20 | HG-5-113-01 | 1.11 | uM | LJP5 | 72 | hr | 1097 | 2722 | 3769 | 0.7222 | 0.6081 |
| BT-20 | HG-5-88-01 | 1.11 | uM | LJP6 | 72 | hr | 1097 | 3264 | 3769 | 0.8660 | 0.8110 |
| BT-20 | Imatinib | 1.11 | uM | LJP6 | 72 | hr | 1097 | 3751 | 3769 | 0.9951 | 0.9931 |
| BT-20 | JNK-9L | 1.11 | uM | LJP6 | 72 | hr | 1097 | 970 | 3769 | 0.2574 | -0.0475 |
| BT-20 | JW-7-24-1 | 1.11 | uM | LJP6 | 72 | hr | 1097 | 2370 | 3769 | 0.6288 | 0.4764 |
| BT-20 | Lapatinib | 1.11 | uM | LJP6 | 72 | hr | 1097 | 3576 | 3769 | 0.9488 | 0.9278 |
| BT-20 | LDN-193189 | 1.11 | uM | LJP5 | 72 | hr | 1097 | 2072 | 3769 | 0.5497 | 0.3648 |
| BT-20 | Linifanib | 1.11 | uM | LJP6 | 72 | hr | 1097 | 3843 | 3769 | 1.0196 | 1.0276 |
| BT-20 | Linsitinib | 1.11 | uM | LJP5 | 72 | hr | 1097 | 3603 | 3769 | 0.9560 | 0.9379 |
| BT-20 | Mitoxantrone | 1.11 | uM | LJP5 | 72 | hr | 1097 | 793 | 3769 | 0.2104 | -0.1139 |
| BT-20 | Mitoxantrone | 1.11 | uM | LJP6 | 72 | hr | 1097 | 789 | 3769 | 0.2094 | -0.1152 |
| BT-20 | MK2206 | 1.11 | uM | LJP6 | 72 | hr | 1097 | 2027 | 3769 | 0.5378 | 0.3481 |
| BT-20 | Neratinib | 1.11 | uM | LJP5 | 72 | hr | 1097 | 2012 | 3769 | 0.5339 | 0.3426 |
| BT-20 | Nilotinib | 1.11 | uM | LJP5 | 72 | hr | 1097 | 3875 | 3769 | 1.0280 | 1.0395 |
| BT-20 | Nintedanib | 1.11 | uM | LJP6 | 72 | hr | 1097 | 2889 | 3769 | 0.7664 | 0.6705 |
| BT-20 | NU7441 | 1.11 | uM | LJP5 | 72 | hr | 1097 | 3731 | 3769 | 0.9900 | 0.9858 |
| BT-20 | Dactolisib | 1.11 | uM | LJP5 | 72 | hr | 1097 | 1231 | 3769 | 0.3266 | 0.0500 |
| BT-20 | NVP-TAE684 | 1.11 | uM | LJP6 | 72 | hr | 1097 | 2943 | 3769 | 0.7808 | 0.6908 |
| BT-20 | Palbociclib | 1.11 | uM | LJP6 | 72 | hr | 1097 | 1542 | 3769 | 0.4091 | 0.1664 |
| BT-20 | PD0325901 | 1.11 | uM | LJP5 | 72 | hr | 1097 | 2377 | 3769 | 0.6306 | 0.4789 |
| BT-20 | PD0325901 | 1.11 | uM | LJP6 | 72 | hr | 1097 | 2340 | 3769 | 0.6209 | 0.4653 |
| BT-20 | PD173074 | 1.11 | uM | LJP6 | 72 | hr | 1097 | 3944 | 3769 | 1.0465 | 1.0655 |
| BT-20 | PD184352 | 1.11 | uM | LJP5 | 72 | hr | 1097 | 3802 | 3769 | 1.0087 | 1.0123 |
| BT-20 | Pelitinib | 1.11 | uM | LJP5 | 72 | hr | 1097 | 2763 | 3769 | 0.7331 | 0.6235 |